Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04133948 |
|---|---|
| Brief Title: | Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI) |
| First Submitted : | October 14, 2019 |
| First Submitted that Met QC Criteria : | October 17, 2019 |
| First Posted : | October 21, 2019 |
| Last Update Submitted that Met QC Criteria : | May 28, 2020 |
| Last Update Posted : | June 1, 2020 |